ImClone Systems Inc (formerly IMCL)

[jbog]

uppy,


From yesterday's conference I took it that they will announce the 3rd line survival trial and the EPIC trial at the AACR meeting in mid April and the Crystal Trial at Asco in June.

Imclone hopes Swog presents the Pancreatic results at Asco also.

At Esmo you'll hear about all the foreign trials, probably something on OPUS and Cairo-2.

Yesterday Eric stated that his and many many onc's are now seeing that the dropout rate (censored patients) when Avastin is used with Folfox is way out of line. That's exactly what I've posted about.

Things will turn.